TY - JOUR T1 - Resuming assisted reproduction services during COVID-19 Pandemic: An Indian experience JF - medRxiv DO - 10.1101/2020.09.20.20198143 SP - 2020.09.20.20198143 AU - Padma Rekha Jirge AU - Sadhana Patwardhan AU - Dilip Paranjape AU - Shishir Narendra Jirge AU - Deepali Atul Bhomkar AU - Shruti Mahesh Chougule AU - Anita Salpekar AU - Deepak Modi Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/09/23/2020.09.20.20198143.abstract N2 - Purpose The pandemic of COVID-19 has affected many countries; and medical services including assisted reproductive treatment (ART) have been hampered. The purpose of the study was to assess the preparedness of ART clinics and staff to resume services; patients’ reasons to initiate treatment and key performance indicators (KPIs) of ART labs during pandemic.Methods Semi-descriptive report of two private in-vitro fertilization (IVF) clinics in Maharashtra, India, when COVID-19 testing for asymptomatic people was unavailable. Time required for replenishing laboratory supplies, and staff preparedness to function under ‘new norms’ of pandemic was documented. Infection mitigation measures at workplace and triaging strategy were evaluated. KPIs of the clinics were evaluated.Results 30% of the patients consulted through telemedicine accepted or were eligible to initiate treatment upon clinic resumption. Lack of safe transport and financial constraints prevented majority from undergoing IVF, and only 9% delayed treatment due to fear of pandemic. With adequate training, staff compliance to meet new demands could be achieved within a week, but supply of consumables was a major constraint. 52 cycles of IVF were performed including fresh cycles and frozen embryo transfers with satisfactory KPIs even during pandemic. Conscious sedation and analgesia during oocyte retrieval was associated with reduced procedure time and no intervention for airway maintenance, compared to general anaesthesia. Self reported pain scores by patients ranged from nil to mild on a graphic rating scale.Conclusion This study provides a practical insight and will aid in forming guidelines for resumption of IVF services during pandemic.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis is an observational studyFunding StatementNo funds, grants, or other support was received for the submitted work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Shreyas Hospital Institutional Ethics Committee (Date: 04/04/20. No.: 003/20). Approval was obtained both for resuming IVF work and for the study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data for this manuscript is available in the central repository of Shreyas Hospital under IVF resumption during COVID and the authors will share the data whenever necessary. ER -